202 related articles for article (PubMed ID: 26103125)
21. Response to unilateral adrenalectomy for aldosterone-producing adenoma: effect of potassium levels and angiotensin responsiveness.
Stowasser M; Klemm SA; Tunny TJ; Storie WJ; Rutherford JC; Gordon RD
Clin Exp Pharmacol Physiol; 1994 Apr; 21(4):319-22. PubMed ID: 7923899
[TBL] [Abstract][Full Text] [Related]
22. Conn's syndrome (primary hyperaldosteronism) simulating polymyositis.
Kaşifoğlu T; Korkmaz C; Paşaoğlu O
Rheumatol Int; 2005 Mar; 25(2):133-4. PubMed ID: 15034751
[TBL] [Abstract][Full Text] [Related]
23. [Ventricular remodeling and matrix metalloproteinase-1 and its tissue inhibitor of metalloproteinase-1 in serum in third trimester of pregnant women with cardiac disease.].
Zhang ZL; Lin JH; Tao RQ
Zhonghua Fu Chan Ke Za Zhi; 2009 Oct; 44(10):731-5. PubMed ID: 20078957
[TBL] [Abstract][Full Text] [Related]
24. A Woman with Normotensive Primary Hyperaldosteronism.
Moradi S; Shafiepour M; Amirbaigloo A
Acta Med Iran; 2016 Feb; 54(2):156-8. PubMed ID: 26997605
[TBL] [Abstract][Full Text] [Related]
25. Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma.
Rossi GP; Sacchetto A; Pavan E; Palatini P; Graniero GR; Canali C; Pessina AC
Circulation; 1997 Mar; 95(6):1471-8. PubMed ID: 9118515
[TBL] [Abstract][Full Text] [Related]
26. Tissue inhibitor of metalloproteinse-1 is a marker of diastolic dysfunction using tissue doppler in patients with type 2 diabetes and hypertension.
Tayebjee MH; Lim HS; Nadar S; MacFadyen RJ; Lip GY
Eur J Clin Invest; 2005 Jan; 35(1):8-12. PubMed ID: 15638813
[TBL] [Abstract][Full Text] [Related]
27. Primary aldosteronism due to unilateral adrenal microadenoma in an elderly patient: efficacy of selective adrenal venous sampling.
Tamura Y; Adachi J; Chiba Y; Mori S; Takeda K; Kasuya Y; Murayama T; Sawabe M; Sasano H; Araki A; Ito H; Horiuchi T
Intern Med; 2008; 47(1):37-42. PubMed ID: 18176003
[TBL] [Abstract][Full Text] [Related]
28. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
29. KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma.
Kitamoto T; Omura M; Suematsu S; Saito J; Nishikawa T
J Hypertens; 2018 Mar; 36(3):619-627. PubMed ID: 29016532
[TBL] [Abstract][Full Text] [Related]
30. Factors determining cardiovascular and renal outcomes after adrenalectomy in patients with aldosterone-producing adrenal adenoma.
Chiou TT; Chiang PH; Fuh M; Liu RT; Lee WC; Lee WC; Ng HY; Tsai YC; Chuang FR; Huang CC; Lee CT
Tohoku J Exp Med; 2009 May; 218(1):17-24. PubMed ID: 19398869
[TBL] [Abstract][Full Text] [Related]
31. Primary aldosteronism with aldosterone-producing adrenal adenoma in a pregnant woman.
Fujiyama S; Mori Y; Matsubara H; Okada S; Maruyama K; Masaki H; Yonemoto T; Nagata T; Umeda Y; Matsuda T; Iwasaka T; Inada M
Intern Med; 1999 Jan; 38(1):36-9. PubMed ID: 10052740
[TBL] [Abstract][Full Text] [Related]
32. Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas.
Karagiannis A; Tziomalos K; Kakafika AI; Athyros VG; Harsoulis F; Mikhailidis DP
Endocr Relat Cancer; 2008 Sep; 15(3):693-700. PubMed ID: 18586836
[TBL] [Abstract][Full Text] [Related]
33. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma.
; Wu VC; Chueh SC; Chang HW; Lin LY; Liu KL; Lin YH; Ho YL; Lin WC; Wang SM; Huang KH; Hung KY; Kao TW; Lin SL; Yen RF; Chen YM; Hsieh BS; Wu KD
Am J Kidney Dis; 2009 Oct; 54(4):665-73. PubMed ID: 19628318
[TBL] [Abstract][Full Text] [Related]
34. A Late Diagnosis of Primary Aldosteronism.
Zorzi F; Olivieri O; Brazzarola P; Pizzolo F
High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):347-349. PubMed ID: 28293914
[TBL] [Abstract][Full Text] [Related]
35. TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension.
Lindsay MM; Maxwell P; Dunn FG
Hypertension; 2002 Aug; 40(2):136-41. PubMed ID: 12154103
[TBL] [Abstract][Full Text] [Related]
36. Plasma aldosterone and left ventricular diastolic function in treatment-naïve patients with hypertension: tissue-Doppler imaging study.
Catena C; Verheyen N; Pilz S; Kraigher-Krainer E; Tomaschitz A; Sechi LA; Pieske B
Hypertension; 2015 Jun; 65(6):1231-7. PubMed ID: 25801873
[TBL] [Abstract][Full Text] [Related]
37. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
[TBL] [Abstract][Full Text] [Related]
38. Incidence and factors of post-adrenalectomy hyperkalemia in patients with aldosterone producing adenoma.
Chiang WF; Cheng CJ; Wu ST; Sun GH; Lin MY; Sung CC; Lin SH
Clin Chim Acta; 2013 Sep; 424():114-8. PubMed ID: 23727469
[TBL] [Abstract][Full Text] [Related]
39. [Normokalaemic primary aldosteronism due to an aldosterone-producing adrenal adenoma--Case 06/2009].
Guthoff M; Schnauder G; Kirchhoff K; Kurth R; Horger M; Müssig K
Dtsch Med Wochenschr; 2009 Jul; 134(31-32):1582. PubMed ID: 19629922
[TBL] [Abstract][Full Text] [Related]
40. A Comparison of Adrenalectomy and Eplerenone on Vascular Function in Patients with Aldosterone-producing Adenoma.
Kishimoto S; Oki K; Maruhashi T; Kajikawa M; Hashimoto H; Takaeko Y; Harada T; Yamaji T; Han Y; Kihara Y; Chayama K; Goto C; Yusoff FM; Nakashima A; Higashi Y
J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32818224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
